Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Merck claims prostaglandin analogues as EP4 receptor agonists for ocular and bone conditions

Nov. 24, 2004

CA4P enters phase II study

Nov. 23, 2004

ISTA licenses U.S. rights for ecabet sodium for dry eye

Nov. 22, 2004

Disappointing preliminary results of Trabio study

Nov. 12, 2004

Use of diazoxide for treatment of ischemia retinae claimed in CNRS patent

Nov. 11, 2004

New clinical data on the efficacy of SnET2 photodynamic therapy in AMD

Nov. 10, 2004

Anecortave acetate shows efficacy in maintaining visual acuity of patients with wet AMD

Nov. 10, 2004

Long-term benefits of ranibizumab in neovascular AMD patients

Nov. 9, 2004

Inspire licenses novel glaucoma technology

Nov. 9, 2004

Serotonin receptor agonists for treatment of ocular hypertension and glaucoma

Nov. 4, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...